![](/img/cover-not-exists.png)
Resistance of KRAS Mutant Colon Cancers to Cetuximab May Be Overcome Through Antibody Engineering
A. Jain, B. Poonia, W.S. Twadell, E. So, R. Vyzasatya, N.N. Hanna, H.R. Alexander, S.B. Kesmodel, S. Chan, H. Olsen, E. Merigeon, D. Block, H. Yfantis, L. Cai, S. StromeVolume:
172
Year:
2012
Language:
english
DOI:
10.1016/j.jss.2011.11.277
File:
PDF, 252 KB
english, 2012